News

Zacks Investment Research on MSN9hOpinion
Top Research Reports for Visa, AstraZeneca & Shell
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...
Roper Technologies, Inc. ROP is benefiting from strength across its segments. Solid momentum across the Deltek, Vertafore, ...
Roper St. Francis Berkeley Hospital once again secured the highest possible mark for patient safety, earning an “A” grade from The Leapfrog Group for the fifth consecutive time.
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...
Roper Technologies ROP has outperformed the market over the past 10 years by 2.47% on an annualized basis producing an ...
Detailed price information for Klaviyo Inc Series A (KVYO-N) from The Globe and Mail including charting and trades.
Fintel reports that on May 5, 2025, William Blair initiated coverage of Roper Technologies (NasdaqGS:ROP) with a Outperform recommendation. Analyst Price Forecast Suggests 14.18% Upside As of April 24 ...
Roper Technologies remains resilient amid economic uncertainty, benefiting from its focus on vertical software companies and high recurring revenue, making it immune to tariffs. The company’s Q1 ...
Conestoga Capital Advisors, an asset management company, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Roper Technologies has a 1-year low of $499.47 and a 1-year high of $595.17. Roper Technologies ( NYSE:ROP – Get Free Report ) last announced its quarterly earnings data on Monday, April 28th.